Blood test trial aims to personalize breast cancer care
NCT ID NCT06833853
Summary
This study aims to learn if special blood tests that detect cancer cells and genetic material can help doctors make better treatment decisions for people with advanced breast cancer. Researchers will observe 187 patients with metastatic breast cancer who are already receiving these blood tests as part of their standard care. The study will track whether these test results actually help doctors choose treatments or assess how well treatments are working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER (MBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
Contact
Conditions
Explore the condition pages connected to this study.